The Investor Relations website contains information about Mallinckrodt's business for stockholders, potential investors, and financial analysts.
People also ask
What happened to Mallinckrodt stock?
Who owns Mallinckrodt?
What is the market cap of Mallinckrodt?
Is Mallinckrodt publicly traded?
Looking for Mallinckrodt Pharmaceuticals investor information? Visit the site to see current stock prices, annual reports, presentations and more.
Investor Relations. Back; Annual Reports. Back; Annual Reports · Quarterly & Other ... Annual report which provides a comprehensive overview of the company for ...
Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. ... derek.belz@mnk.com. Media Michael ...
Aug 9, 2023 · Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the ...
Investor Relations Daniel J. Speciale Global Corporate Controller & Chief Investor Relations Officer 314-654-3638 daniel.speciale@mnk.com. Derek Belz Vice ...
Apr 24, 2023 · daniel.speciale@mnk.com. Derek Belz Vice President, Investor Relations 314-654-3950 derek.belz@mnk.com. Media Michael Freitag / Aaron Palash ...
May 9, 2023 · Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the ...
Mar 10, 2023 · ... Investor Relations page of our website for this information. As noted in the earnings release, our fourth quarter ended on December 30th ...
May 9, 2023 · Mallinckrodt plc (MNK) Q1 2023 Earnings Conference Call May 9, 2023 8:30 AM ETCompany ParticipantsDan Speciale – Chief Investor Relations ...